Nasdaq News

The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.

The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.

The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.

The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.

SPECIAL ALERT: The June episode of the Zacks Ultimate Strategy Session will be available for viewing no later than Wednesday, June 10. Kevin Matras, Kevin Cook, Brian Bolan and Sheraz Mian will cover the investment landscape from several angles in this popular event. Don’t

As Americans have spent weeks staying put at home to slow the spread of COVID-19, the stock market has gone on a wild ride, first crashing and then rallying even as unemployment reached record highs. 

The stock market has taken investors on quite a roller-coaster ride in 2020. After reaching all-time highs in February, the S&P 500 and Dow Jones Industrial Average plunged by as much as 40% as the COVID-19 pandemic intensified. Since then, the major indexes have rebounded s

It is no secret that prescription drug prices in America are the highest among all developed nations. A variety of factors have contributed to the issue, such as a lack of universal healthcare coverage, the staggering cost of conducting clinical trials to get drugs to approval,

Blink and you would have missed Veeva Systems' (NYSE: VEEV) coronavirus slump. The stock is up 55% 2020 to date, driven by continued migration to its cloud-based software for pharmaceutical and biotech companies. The battle to develop treatments for infectious disease and other

Image source: The Motley Fool.

During the pandemic, one might think Dollar Tree (NASDAQ: DLTR) stock would have performed quite well. Its grocery business kept it "essential," and low price points make it affordable to shoppers from any income level.

These days, Regeneron (NASDAQ: REGN) seems to be the miracle stock that biotech investors are looking for. Sales of its biologic drug for ocular health, Eylea, and its anti-inflammatory drug, Dupixent, are soaring. Meanwhile, the company is also developing a promising antibody

Millions of seniors look to Social Security to help fund their retirements. In fact, those benefits are a major source of income for 64% of retirees today, according to the Society of Actuaries.

While companies that produce the newest tech innovations might seem more exciting to invest in than those that purvey burritos or toilet paper, investors' focus should be on growing their money, and growth can come from anywhere.

(RTTNews) - PepsiCo, Inc. (PEP) announced the appointment of Wern-Yuen Tan as Chief Executive Officer of Asia Pacific, Australia, New Zealand and China. Tan, effective June 15, 2020. Prior to PepsiCo, Tan served as President and CEO of Walmart China. Ram Krishnan, CEO of APAC, w

(RTTNews) - Wizz Air Holdings Plc (WIZZ.L) reported Wednesday that its fiscal 2020 profit before tax surged 128.2 percent to 294.1 million euros from last year's 128.9 million euros. Net profit was 281.1 million euros, up from prior year's 123 million euros.

(RTTNews) - Today's Daily Dose brings you news about Agenus' foray into COVID-19 drug development space; AMERI Holdings' progress in glioblastoma multiforme drug development; BrainStorm Cell's anticipated milestone related to its amyotrophic lateral sclerosis drug candidate; Cit

Image source: The Motley Fool.

The Swiss economy contracted 2.6% in the first quarter compared with the last three months of 2019 as the coronavirus pandemic slammed output, data showed on Wednesday.

The Indonesian rupiah hit a near three-month high on Wednesday as strong demand from yield-seeking investors extended a rally in government bonds, while most other Asian currencies gained on hopes of more stimulus and a global economic recovery.